SCHEDULE: Evolent Health: Eventide, Kuruvilla, John Report 0.0% Stake
Beneficial Ownership Report
Eventide Asset Management, Finny Kuruvilla, and Robin C. John have filed an amended Schedule 13G, disclosing a 0.0% beneficial ownership in Evolent Health, Inc. Class A Common Stock as of December 31, 2025.
Summary
- Eventide Asset Management, LLC, Finny Kuruvilla, M.D., Ph.D., and Robin C. John jointly filed an Amendment No. 3 to Schedule 13G regarding their beneficial ownership of Evolent Health, Inc. Class A Common Stock.
- As of December 31, 2025, each reporting person beneficially owned 1,713 shares of Class A Common Stock.
- This ownership represents 0.0% of the total outstanding Class A Common Stock.
- Eventide Asset Management, LLC holds sole voting and dispositive power over 1,713 shares.
- Finny Kuruvilla, M.D., Ph.D., and Robin C. John each hold shared voting and dispositive power over 1,713 shares.
- The securities were acquired and are held in the ordinary course of business and not for the purpose of changing or influencing control of the issuer.
Sentiment
Score: 5
Explanation: StockSavvy.ai views this filing as neutral, as it is a standard disclosure of a non-material ownership stake (0.0%) and provides no new information regarding the company's operational or financial performance.
Positives
- NA
Negatives
- NA
Risks
- NA
Future Outlook
NA
Industry Context
StockSavvy.ai notes that Schedule 13G filings are routine disclosures by passive investors who own less than 20% of a company's stock and do not intend to influence control. This particular filing, showing a 0.0% stake, indicates a minimal, non-strategic position by the reporting entities in Evolent Health, Inc.
Stakeholder Impact
- Shareholders: Minimal to no impact, as the reported ownership is 0.0% and does not suggest any change in control or strategic direction.
- Employees, Customers, Suppliers, Creditors: No direct impact from this ownership disclosure.
Key Dates
| Date | Description |
|---|---|
| 12/31/2025 | Date of event which requires filing of this statement, reflecting the reported beneficial ownership. |
| 02/13/2026 | Date the Schedule 13G Amendment No. 3 was signed and filed. |
Keywords
Evolent Health, EVH, Schedule 13G, Beneficial Ownership, Eventide Asset Management, Finny Kuruvilla, Robin C. John, Class A Common Stock, SEC Filing, Investment Adviser
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.